Clinical Trials Update: June 6, 2005
Heart Defect Esophageal Cancer Hodgkin's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Mount Sinai Medical Center is recruiting people for an investigational nuclear imaging study of heart tissue muscle blood flow abnormality. To qualify, you must be 18 or older, have a suspected decrease in the blood supply to a bodily organ, tissue, or part caused by constriction or obstruction of the blood vessels, and be a post menopausal, surgically sterile, or non-pregnant and non-lactating female. Research site located in New York, NY.
The purpose of this study is to investigate the effects of the drug cetuximab on esophageal cancer. Cetuximab will be given intravenously once every week. Participants must have histologically confirmed adenocarcinoma of the esophagus and have received one prior chemotherapy. Research site located in Elgin, Ill.
The purpose of this study is to test how those with Hodgkin's disease that has recurred and/or become resistant to standard initial treatment responds to an experimental treatment. The University of Virginia Health System Cancer Center seeks children ages one to 21 for a study of the treatment of refractory or relapsed Hodgkin's Disease. Research site located in Charlottesville, Va.
Copyright 2005 CenterWatch. All rights reserved.